Skip to content

Outcome Study of Total Knee Arthroplasty in Asian Patients

Clinical Evaluation of the Low Contact Stress (LCS) Classic and Universal Mobile-bearing Total Knee System. The Asian LCS User Group - 'The Dragon Knee Study'

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00733694
Acronym
DRAGON
Enrollment
607
Registered
2008-08-13
Start date
2000-04-01
Completion date
2008-04-01
Last updated
2025-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Keywords

Arthroplasty, Replacement, Knee,LCS

Brief summary

To determine how the LCS mobile bearing knee system works within the Asian Population.

Detailed description

The objective of this clinical evaluation is to compile a profile of the performance of the LCS Mobile bearing total knee system in normal clinical practice within the Asian Population. Performance will be assessed using specific surgeon and patient based outcome scores. Total subject enrolled 505; 6 subjects did not receive device. Total subjects received device 499. Among those who received devices, 391 subjects unilateral and 108 bilateral, therefore, total 607 knees in the study

Interventions

DEVICELCS® Complete™ Mobile Bearing Knee Systems

An orthopaedic implant for primary total knee replacement with a mobile bearing knee

Sponsors

DePuy International
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 75 Years
Healthy volunteers
No

Inclusion criteria

* Administrative - the patient is able to understand the evaluation, is able to give consent and will comply with the postoperative follow up regime. * Diagnosis - idiopathic osteoarthritis, rheumatoid arthritis, post traumatic arthritis or any other pathology that in the opinion of the clinical investigator requires a primary total knee arthroplasty. * Implant suitability - patients who in the opinion of the Clinical Investigator are considered suitable for treatment with a mobile bearing knee system (the LCS Classic or Universal). * Bilateral patients - simultaneous bilateral patients are included. Staged bilateral patients are included if the second procedure is performed within the one-year recruitment period. Staged bilateral patients where the second procedure is performed outside of the one-year recruitment period will only be included if the second procedure is performed within 6 months of the end of the one-year recruitment period. * Age - the upper age limit is set at 75 years and expected to live through the 5 years study period.vi. Ethnic Origin - patients must be Asian in ethnic origin * Unicondylar / High Tibial Osteotomy (HTO) conversion - patients that are being converted from a unicondylar / HTO procedure are included providing the reason for conversion is due to progression of the disease process affecting the other condyle. Patients that are converted and have evidence of infection / aseptic loosening / loss of bone stock are excluded.

Exclusion criteria

* Patients with a known history of poor compliance to medical treatment. * Patients that require revision surgery * Patients with gross ligamentous insufficiency. * Patients with a severe valgus deformity (15 degrees or greater) * Patients with a severe varus deformity (20 degrees or greater) * Patients with a fixed flexion contracture (30 degrees or greater) * Patients over the age of 75 years.

Design outcomes

Primary

MeasureTime frameDescription
Change in Oxford Knee Score5 yearsOxford Knee Score will be summarized pre-operatively and at each subsequent post-operative follow-up. The change from pre-op to final post-operative assessment at 5 years will be derived and used as the analysis variable.

Secondary

MeasureTime frameDescription
Adverse Events5 yearsAll intraoperative and postoperative adverse incidences/complications and their relationship to the knee will be collected
Change in Quality of Life Score (SF-36), Knee Society Score, Anterior Pain and radiographic/radiolucent details from pre-op to 5 year post-op follow up.5 years

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026